Theravance Biopharma
TBPH
TBPH
84 hedge funds and large institutions have $1.62B invested in Theravance Biopharma in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 12 closing their positions.
Holders
84
Holders Change
-10
Holders Change %
-10.64%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
3
Increased
36
Reduced
23
Closed
12
Calls
$394K
Puts
$2.19M
Net Calls
-$1.79M
Net Calls Change
-$860K
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$78.8M |
2 |
SAM
2
Senzar Asset Management
New York
|
$6.24M |
3 |
3
BlackRock
New York
|
$130M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$113M |
5 |
C
5
Chescapmanager
Baltimore,
Maryland
|
$9.64M |